Trial Profile
Tocilizumab in Giant Cell Arteritis: Multicenter Open-Label Study of 22 Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis
- Focus Therapeutic Use
- 26 Aug 2015 New trial record